日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Renoprotective Effects of Goreisan via Modulation of RAAS Activity, Oxidative Stress, and AQP2 Trafficking in a Rat Model of Nephrotic Syndrome.

五里散通过调节肾素-血管紧张素-醛固酮系统活性、氧化应激和AQP2转运在肾病综合征大鼠模型中发挥肾脏保护作用。

期刊:Biomedicines
影响因子:3.9
doi:10.3390/biomedicines14010008
Shimizu Mao, Goto Shunsuke, Yamatani Satoshi, Sakamoto Kazuo, Kono Keiji, Fujii Hideki
心血管
AQP2
氧化应激
发表日期：2025
文献求助 收藏

Association of abnormalities in electrocardiography and ultrasonic echocardiography with the occurrence of cardiovascular disease in patients with advanced chronic kidney disease

心电图和超声心动图异常与晚期慢性肾脏病患者心血管疾病发生率的相关性

期刊:Clinical and Experimental Nephrology
影响因子:1.7
doi:10.1007/s10157-023-02437-8
Hirabayashi, Ken; Fujii, Hideki; Kono, Keiji; Yamatani, Satoshi; Shimizu, Mao; Watanabe, Kentaro; Sakamoto, Kazuo; Goto, Shunsuke; Nishi, Shinichi
心血管疾病
心血管
发表日期：2024
文献求助 收藏

Comparison of two protocols for steroid pulse therapy in patients with IgA nephropathy: a retrospective observational study

比较两种激素冲击疗法治疗IgA肾病患者的方案：一项回顾性观察研究

期刊:BMC Nephrology
影响因子:2.4
doi:10.1186/s12882-022-02791-x
Yamatani, Satoshi; Kono, Keiji; Fujii, Hideki; Hirabayashi, Ken; Shimizu, Mao; Watanabe, Kentaro; Goto, Shunsuke; Nishi, Shinichi
IgA
免疫/内分泌
发表日期：2022
文献求助 收藏

Changes in blood pressure during treatment with the tyrosine kinase inhibitor lenvatinib

使用酪氨酸激酶抑制剂乐伐替尼治疗期间血压的变化

期刊:Clinical Kidney Journal
影响因子:4.6
doi:10.1093/ckj/sfaa137
Saito, Kei; Fujii, Hideki; Kono, Keiji; Hirabayashi, Ken; Yamatani, Satoshi; Watanabe, Kentaro; Goto, Shunsuke; Komatsu, Shohei; Fukumoto, Takumi; Nishi, Shinichi
信号转导
发表日期：2021
文献求助 收藏